PiCSO highlighted at TCT as novel therapy

179

Miracor Medical Systems have reported that, during this year’s Transcatheter Cardiovascular Therapeutics meeting (11–15 October, San Francisco, USA), PiCSO has been highlighted in several sessions as offering new hope for cardioprotection during percutaneous coronary intervention (PCI).  A press release reports that myocardial salvage and the need for cardioprotection for patients with acute myocardial infarction was a focus topic at this year’s TCT conference.


According to the press release, PiCSO is applied during the stenting procedure, directly following flow restoration and increases myocardial perfusion and microcirculation, thereby preventing so-called reperfusion injury, damage to the myocardium caused by the stenting procedure itself.


Antonio Colombo, director of Cardiovascular Interventions at San Raffaele Scientific Institute, Columbus Hospital in Milan, Italy, says: “Further therapies to protect my patients—especially during complex PCI procedures are needed. At San Raffaele Hospital, we have used PiCSO in elective, as well as acute, high risk PCI procedures and are pleased to see that PiCSO can be applied without significant interruption of our standard workflows and without increasing the risk for the patient. Once the PiCSO catheter is placed in the coronary sinus and connected to the PiCSO console, therapy is applied fully automatically so that I can focus on the stenting procedure, knowing that the patient’s heart is protected by PiCSO.”

(Visited 14 times, 1 visits today)